HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion

  • Yoav Chemla
  • , Orit Itzhaki
  • , Stav Melamed
  • , Chen Weller
  • , Yuval Sade
  • , Paulee Manich
  • , Keren Reshef
  • , Nicolas Xenidis
  • , Avishai Maliah
  • , Gilad Levy
  • , Roma Parikh
  • , Osnat Bartok
  • , Opal Levy
  • , Itay Tal
  • , Gal Aziel
  • , Abraham Nissani
  • , Sharon Yunger
  • , Daniela Likonen
  • , Vitaly Kliminsky
  • , Tamar Golan
  • Coralie Capron, Valentina Ace, Ronen Levy, Diana Rasoulouniriana, Zohar Eyal, Yuval Barzilay, Roi Balaban, Aseel Khateeb, Rami Khosravi, Amir Grau, Tamar Ziv, Polina Greenberg, Dvir Netanely, Hananya Vaknin, Xunwei Wu, Yael Amitay, Ronen Brenner, Julia María Martínez Gómez, Dov Hershkovitz, Tal Yardeni, Valentina Zemser-Werner, Oren Kobiler, Yael Friedmann, David Bassan, Ron Shamir, Lea Eisenbach, Nadine Santana-Magal, Michael Milyavsky, Galit Eisenberg, Leeat Keren, Merav Cohen, Dvir Gur, Boaz Barak, Michal Lotem, David Sprinzak, Shoshana Greenberger, David Fisher, Michal J. Besser, Mehdi Khaled*, Pierre Close*, Ronnie Shapira*, Sebastien Apcher*, Asaf Madi*, Mitchell P. Levesque*, Francessca Rapino*, Yaron Carmi*, Shivang Parikh*, Yardena Samuels*, Carmit Levy*
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

While melanoma cells often express a high burden of mutated proteins, the infiltration of reactive T cells rarely results in tumor-eradicating immunity. We discovered that large extracellular vesicles, known as melanosomes, secreted by melanoma cells are decorated with major histocompatibility complex (MHC) molecules that stimulate CD8+ T cells through their T cell receptor (TCR), causing T cell dysfunction and apoptosis. Immunopeptidomic and T cell receptor sequencing (TCR-seq) analyses revealed that these melanosomes carry MHC-bound tumor-associated antigens with higher affinity and immunogenicity, which compete with their tumor cell of origin for direct TCR-MHC interactions. Analysis of biopsies from melanoma patients confirmed that melanosomes trap infiltrating lymphocytes, induce partial activation, and decrease CD8+ T cell cytotoxicity. Inhibition of melanosome secretion in vivo significantly reduced tumor immune evasion. These findings suggest that MHC export protects melanoma from the cytotoxic effects of T cells. Our study highlights a novel immune evasion mechanism and proposes a therapeutic avenue to enhance tumor immunity.

Original languageEnglish
Pages (from-to)233-251.e29
JournalCell
Volume189
Issue number1
DOIs
Publication statusPublished Online - 15 Dec 2025

Funding

C.L. acknoledges that this work was funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program European Union. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the ERCEA. Neither the European Union nor the granting authority can be held responsible for them (C.L., grant agreement no. 726225). C.L. acknowledges the Tel Aviv University Gray Medical School core facility, Medina and Elisha with endless gratitude, and Yuval and Omer for exponential joy. D.F. acknowledges the NIH grants NCI P01 CA163222 and NIAMS R01 AR043369-27 and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. A.M. acknowledges the Mantoux Bioinformatics Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine and specifically Dr. Avital Sarusi Portuguez.

All Science Journal Classification (ASJC) codes

  • General Biochemistry,Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion'. Together they form a unique fingerprint.

Cite this